We have identified a compound, PF-543 (a potent sphingosine kinase 1 inhibitor) which has a dramatic effect on hypertrophic-induced myocardial apoptosis, which is the major killer in humans suffering from PAH. Here, SPHK1 is linked to pulmonary arterial hypertension.